Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Reiterates Buy on Analog Devices (ADI); $37 PT
-
Canaccord Adams Sees Bankrate (RATE) As An Attractive Takeover
-
Pharmacopeia (PCOP) Surges On Positive DARA Phase 2a Trial Data
-
Unusual 11 Mid-Day Movers 5/13: IOMI, CSIQ, FSYS, WCI, USNA Higher; NXTM, USS, CRZ, IMB Lower
-
Canaccord Adams Adds VistaPrint (VPRT) to Best Ideas List
-
Canaccord Reiterates Buy on Research In Motion (RIMM); $200 PT
-
Canaccord Adams Downgrades NxStage Medical (NXTM) to Hold
-
Canaccord Adams Downgrades Hansen Natural (HANS) to Hold
-
Canaccord Adams Said RIM's BlackBerry Bold Could Become a "Blockbuster" (RIMM)
-
Canaccord Adams Downgrades TELUS Corp (TU) to Hold
-
Color on Canaccord's Upgrade of NVIDIA (NVDA) to Buy
-
Canaccord Upgrades NVIDIA (NVDA) from Sell to Buy
-
Canaccord Adams Raises Price Target on Research In Motion (RIMM) to $200
-
Real Goods Solar (RSOL) IPO Trades Lower
-
Canaccord Positive on Pharmacopeia (PCOP) Into DARA Phase 2a Data
-
Sprint and Clearwire's WiMax Deal a Positive for NextWave (WAVE) - Canaccord
-
Canaccord Adams Cuts Price Target on Internap (INAP) to $3.80
-
Canaccord Adams Trims Price Target on Golden Star Resources (GSS) to $4
-
Real Goods Solar (RSOL) IPO Prices at $10
-
Unusual 11 Mid-Day Movers 5/6: IAR, IPHS, RAS, CRBC Higher; OMPI, IBI, DSCM, PSS Lower
-
Canaccord Adams Removed Drugstore.com (DSCM) from Best Idea List
-
Canaccord Adams Upgrades Microsoft (MSFT) to Buy
-
Canaccord Adams Boosts Ests and PT on Research In Motion (RIMM), Cites New Devices and Upgrade Cycle
-
Canaccord Adams Very Bullish On Research In Motion (RIMM), Sees A Number of Upcoming Catalysts
-
Canaccord Adams Bumps Price Target on Wright Medical (WMGI) to $38
-
Canaccord Adams Trims Price Target on Bottomline Tech (EPAY) to $13, Maintains Hold
-
Canaccord Adams Boosts Price Target on Data Domain (DDUP) to $33.25, Following Strong Q1
-
Canaccord Adams Upgrades Newfield Exploration (NFX) to Buy
-
NextWave Wireless (WAVE) Soars On Plans to Sell US Wireless Spectrum
-
Canaccord Adams Raises Price Tgt on Quicksilver (KWK) to $50
-
Canaccord Adams upgrades Rackable Systems (RACK) to Buy
-
Canaccord Adams Starts Netezza (NZ) at Buy
-
Real Goods Solar (RSOL) Sees IPO Price of $10-$12
-
Canaccord Adams Upgrades (IBM) to Buy
-
Canaccord Adams Adds First Solar (FSLR) To Their Best Ideas List
-
Canaccord Adams Upgrades Cerner (CERN) to Buy
-
Canaccord Raises PT on Schnitzer Steel (SCHN) from $80 to $88
-
Canaccord Adams Starts Bionovo (BNVI) at Buy
-
Canaccord Adams Addsm drugstore.com (DSCM) to Best Ideas List
-
Canaccord Adams Starts NextWave Wireless (WAVE) at Speculative Buy
-
Canaccord Slashes Price Target on Hana Biosciences to $1.10 (HNAB)
-
Canaccord Downgrades Elan Corp. (ELN) to Sell
-
Canaccord Starts Titan Pharmaceuticals (TTP) at Buy
-
Canaccord Starts Orbitz (OWW) at Sell; $4.50 PT
-
Color on Canaccord Coverage of priceline.com (PCLN)
-
Expedia (EXPE) Will Trade in Holding Pattern For Now -Canaccord
-
Color on Canaccord Initiation of Ctrip.com (CTRP) at Buy
-
Canaccord Starts priceline.com (PCLN) at Hold
-
Canaccord Starts Expedia (EXPE) at Hold
-
Canaccord Starts Ctrip.com (CTRP) at Buy
